ANP Receptor Subtypes on Cells of the Aqueous Inflow and Outflow
Principal Investigator
Richard Crook, PhD
University of California, San Francisco
San Francisco, CA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$24,582
Active Dates
April 01, 1994 - March 31, 1995
Grant ID
G1994316
Summary
Recent genetic evidence has raised the possibility that a particular protein in the eye (a neuropeptide receptor, ANPR-A) could be involved in the etiology of juvenile glaucoma in one family. This project aims to identify the location of this protein in tissues in the front of the eye, and to determine how the function of this protein and related proteins are controlled by hormonal and other factors in the eye. An understanding of how this protein functions may provide insights into this form of glaucoma. The ANP receptor subtypes will be distinguished by subtype preferences for various natriuretic peptides resulting in guanylate cyclase activation and by binding of labeled ANP to intact cells. Regulation of ANP receptor subtype function will be studied by measuring the effects of various hormones, neurotransmitters and other activators of second messenger pathways on natriuretic peptide stimulation of guanylate cyclase and labeled ANP binding to intact cells.
Related Grants
National Glaucoma Research
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
National Glaucoma Research
Improving Glaucoma Care with Agentic AI
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Mark Christopher, PhD
Current Organization
University of California, San Diego
Improving Glaucoma Care with Agentic AI
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Mark Christopher, PhD
Current Organization
University of California, San Diego
National Glaucoma Research
Exploring Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Qi Cui, MD, PhD
Current Organization
University of Pennsylvania, Perelman School of Medicine
Exploring Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Qi Cui, MD, PhD
Current Organization
University of Pennsylvania, Perelman School of Medicine